Mahati Avineni

SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.

A. Dey, D. V. Vander Griend, Steven Kregel, 2023, Cancer letters.